Last reviewed · How we verify
Johnson & Johnson
At a glance
| Generic name | Johnson & Johnson |
|---|---|
| Sponsor | Jens D Lundgren, MD |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICU (NA)
- Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens
- Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry
- Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults (NA)
- Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer (NA)
- Effect of PRP With Physiotherapy on Shoulder Impingement (NA)
- Long-acting Spatial Emanators / Repellents (LASER) (NA)
- MULTICENTER, DOUBLE-ARM, PATIENT AND ASSESSOR-MASKED, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL TO COMPARE VISUAL PERFORMANCE OF NEGATIVE AND NEUTRAL ASPHERIC MONOFOCAL INTRAOCULAR LENSES (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Johnson & Johnson CI brief — competitive landscape report
- Johnson & Johnson updates RSS · CI watch RSS
- Jens D Lundgren, MD portfolio CI